These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 23921906)

  • 21. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death.
    Doubeni CA; Corley DA; Jensen CD; Levin TR; Ghai NR; Cannavale K; Zhao WK; Selby K; Buckner-Petty S; Zauber AG; Fletcher RH; Weiss NS; Schottinger JE
    JAMA Netw Open; 2024 Jul; 7(7):e2423671. PubMed ID: 39028667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal Cancer Screening After Sequential Outreach Components in a Demographically Diverse Cohort.
    Podmore C; Selby K; Jensen CD; Zhao WK; Weiss NS; Levin TR; Schottinger J; Doubeni CA; Corley DA
    JAMA Netw Open; 2024 Apr; 7(4):e245295. PubMed ID: 38625704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens.
    Berry E; Miller S; Koch M; Balasubramanian B; Argenbright K; Gupta S
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):647-653. PubMed ID: 31085338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Text Messaging and Opt-out Mailed Outreach in Colorectal Cancer Screening: a Randomized Clinical Trial.
    Huf SW; Asch DA; Volpp KG; Reitz C; Mehta SJ
    J Gen Intern Med; 2021 Jul; 36(7):1958-1964. PubMed ID: 33511567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mailed fecal testing and patient navigation versus usual care to improve rates of colorectal cancer screening and follow-up colonoscopy in rural Medicaid enrollees: a cluster-randomized controlled trial.
    Coronado GD; Leo MC; Ramsey K; Coury J; Petrik AF; Patzel M; Kenzie ES; Thompson JH; Brodt E; Mummadi R; Elder N; Davis MM
    Implement Sci Commun; 2022 Apr; 3(1):42. PubMed ID: 35418107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Combined Patient Decision Aid and Patient Navigation vs Usual Care for Colorectal Cancer Screening in a Vulnerable Patient Population: A Randomized Clinical Trial.
    Reuland DS; Brenner AT; Hoffman R; McWilliams A; Rhyne RL; Getrich C; Tapp H; Weaver MA; Callan D; Cubillos L; Urquieta de Hernandez B; Pignone MP
    JAMA Intern Med; 2017 Jul; 177(7):967-974. PubMed ID: 28505217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Colorectal Cancer Screening Sustained with Mailed Fecal Immunochemical Test Outreach.
    Lee B; Keyes E; Rachocki C; Grimes B; Chen E; Vittinghoff E; Ladabaum U; Somsouk M
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1326-1333.e4. PubMed ID: 34280552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Behavioral Economics Principles Improves Participation in Mailed Outreach for Colorectal Cancer Screening.
    Bakr O; Afsar-Manesh N; Raja N; Dermenchyan A; Goldstein NJ; Shu SB; May FP
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00115. PubMed ID: 31972609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve three-year adherence to colorectal cancer screening among patients cared for in rural community health centers.
    Davis TC; Morris JD; Reed EH; Curtis LM; Wolf MS; Davis AB; Arnold CL
    Contemp Clin Trials; 2022 Feb; 113():106654. PubMed ID: 34906745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.
    Selby K; Jensen CD; Levin TR; Lee JK; Schottinger JE; Zhao WK; Corley DA; Doubeni CA
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):145-152. PubMed ID: 33010408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
    González-López N; Quintero E; Gimeno-Garcia AZ; Bujanda L; Banales J; Cubiella J; Salve-Bouzo M; Herrero-Rivas JM; Cid-Delgado E; Alvarez-Sanchez V; Ledo-Rodríguez A; de-Castro-Parga ML; Fernández-Poceiro R; Sanromán-Álvarez L; Santiago-Garcia J; Herreros-de-Tejada A; Ocaña-Bombardo T; Balaguer F; Rodríguez-Soler M; Jover R; Ponce M; Alvarez-Urturi C; Bessa X; Roncales MP; Sopeña F; Lanas A; Nicolás-Pérez D; Adrián-de-Ganzo Z; Carrillo-Palau M; González-Dávila E;
    PLoS Med; 2023 Oct; 20(10):e1004298. PubMed ID: 37874831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program.
    Green BB; Baldwin LM; West II; Schwartz M; Coronado GD
    J Prim Care Community Health; 2020; 11():2150132720958525. PubMed ID: 32912056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mailed Outreach Is Superior to Usual Care Alone for Colorectal Cancer Screening in the USA: A Systematic Review and Meta-analysis.
    Jager M; Demb J; Asghar A; Selby K; Mello EM; Heskett KM; Lieberman AJ; Geng Z; Bharti B; Singh S; Gupta S
    Dig Dis Sci; 2019 Sep; 64(9):2489-2496. PubMed ID: 30915656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mail-Based Self-Sampling to Complete Colorectal Cancer Screening: Accelerating Colorectal Cancer Screening and Follow-up Through Implementation Science.
    Gupta S; Barnes A; Brenner AT; Campbell J; Davis M; English K; Hoover S; Kim K; Kobrin S; Lance P; Mishra SI; Oliveri JM; Reuland DS; Subramanian S; Coronado GD
    Prev Chronic Dis; 2023 Dec; 20():E112. PubMed ID: 38060411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population.
    Karlitz JJ; Fendrick AM; Bhatt J; Coronado GD; Jeyakumar S; Smith NJ; Plescia M; Brooks D; Limburg P; Lieberman D
    Popul Health Manag; 2022 Jun; 25(3):343-351. PubMed ID: 34958279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.
    Green BB; Wang CY; Anderson ML; Chubak J; Meenan RT; Vernon SW; Fuller S
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):301-11. PubMed ID: 23460053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mailed invitations for colorectal screening are effective in increasing screening participation in uninsured adults with faecal immunochemical testing: the preferred screening modality.
    LoConte NK; Deming DA
    Evid Based Med; 2014 Aug; 19(4):145. PubMed ID: 24727711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.